Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
JNJ.US
id: 561

J&J Talc Products Adverse Effect Securities Litigation

D. New Jersey
Court
18-CV-01833
Case number
Investors allege that for a period from February 22, 2023, to February 7, 2018, the Company and its Leaders made false or misleading statements, and failed to disclose that:
  • J&J has known for decades that its talc products include asbestos fibers and that exposure to those fibers can cause ovarian cancer and mesothelioma.
  • The Company could conceal contingent liabilities and loss of future revenues from the product.
As a result of the Company’s actions, Investors could suffer damages when the true details entered the market.
Alleged Offence
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
13 December 2018
Filing date
08 February 2018
Judge
Hon. Freda L. Wolfson
Collecting participants…

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers...

    Ticker
    JNJ.US
    ISIN
    US4781601046
    CIK
    200406
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Country
    USA
    Address
    One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933